Abstract
In the presence of KF as base and THF as solvent, the tandem Michael addition-elimination reaction of different 5-alkoxy-3,4-dihalo-2(5H)-furanones with aminomethyl benzimidazoles at room temperature gave 21 target compounds simultaneously containing both bioactive benzimidazole and 2(5H)-furanone moieties in yields of 62-88 % (mostly over 71 %). The structures of all the newly synthesized compounds were elucidated and confirmed by FTIR, UV, 1H NMR, 13C NMR, mass spectroscopy and elemental analysis. The simple one-pot synthetic method provides a brief route for the introduction of the benzimidazole unit into 2(5H)-furanone derivatives under mild conditions without any metal catalysts. This transformation also affords an important synthetic strategy for the series 2(5H)-furanone derivatives, as well as a basis for the activity test of these potential drug molecules.
Keywords: Benzimidazole, bioactive units, combination, Csp2-N bond formation, 2(5H)-furanone, metal-free catalysis, Michael addition-elimination reaction, one-pot synthesis.
Letters in Organic Chemistry
Title:One-Pot Synthesis of 5-Alkoxy-4-amino-3-halo-2(5H)-furanones Containing Benzimidazole Moiety in the Absence of Metal Catalyst
Volume: 12 Issue: 5
Author(s): Pai Peng, Min-Hua Feng, Jie Shi, Jia-Li Zheng, Yan-Cheng Wu, Zhao-Yang Wang and Ren-Hong Chen
Affiliation:
Keywords: Benzimidazole, bioactive units, combination, Csp2-N bond formation, 2(5H)-furanone, metal-free catalysis, Michael addition-elimination reaction, one-pot synthesis.
Abstract: In the presence of KF as base and THF as solvent, the tandem Michael addition-elimination reaction of different 5-alkoxy-3,4-dihalo-2(5H)-furanones with aminomethyl benzimidazoles at room temperature gave 21 target compounds simultaneously containing both bioactive benzimidazole and 2(5H)-furanone moieties in yields of 62-88 % (mostly over 71 %). The structures of all the newly synthesized compounds were elucidated and confirmed by FTIR, UV, 1H NMR, 13C NMR, mass spectroscopy and elemental analysis. The simple one-pot synthetic method provides a brief route for the introduction of the benzimidazole unit into 2(5H)-furanone derivatives under mild conditions without any metal catalysts. This transformation also affords an important synthetic strategy for the series 2(5H)-furanone derivatives, as well as a basis for the activity test of these potential drug molecules.
Export Options
About this article
Cite this article as:
Peng Pai, Feng Min-Hua, Shi Jie, Zheng Jia-Li, Wu Yan-Cheng, Wang Zhao-Yang and Chen Ren-Hong, One-Pot Synthesis of 5-Alkoxy-4-amino-3-halo-2(5H)-furanones Containing Benzimidazole Moiety in the Absence of Metal Catalyst, Letters in Organic Chemistry 2015; 12 (5) . https://dx.doi.org/10.2174/1570178612666150305002655
DOI https://dx.doi.org/10.2174/1570178612666150305002655 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nimesulide Apparent Solubility Enhancement with Natural Cyclodextrins and their Polymers
Letters in Drug Design & Discovery Regulatory Mechanisms of Vanillic Acid in Cardiovascular Diseases: A Review
Current Medicinal Chemistry Valeriana jatamansi Constituent IVHD-valtrate As a Novel Therapeutic Agent to Human Ovarian Cancer: in vitro and in vivo Activities and Mechanisms
Current Cancer Drug Targets Novel Cream Containing Microsponges of Anti-Acne Agent: Formulation Development and Evaluation
Current Drug Delivery Targeted Oncolytic Herpes Simplex Viruses for Aggressive Cancers
Current Pharmaceutical Biotechnology Osteoblasts and Osteoclasts in Bone Remodeling and Inflammation
Current Drug Targets - Inflammation & Allergy An insight into the Interaction between Clopidogrel and Proton Pump Inhibitors
Current Drug Metabolism Viral Proteases as Targets for Drug Design
Current Pharmaceutical Design Chromogranin-A: A Multifaceted Cardiovascular Role in Health and Disease
Current Medicinal Chemistry Cytokine Storm and Neuropathological Alterations in Patients with Neurological Manifestations of COVID-19
Current Alzheimer Research CD26 Inhibition Enhances Perfusion Recovery in ApoE-/-Mice
Current Vascular Pharmacology Nanotechnology in Therapeutics – Current Technologies and Applications
Current Nanoscience Mango Polyphenols and Its Protective Effects on Diseases Associated to Oxidative Stress
Current Pharmaceutical Biotechnology Triterpene Derivatives as Inhibitors of Protein Involved in the Inflammatory Process: Molecules Interfering with Phospholipase A2, Cycloxygenase, and Lipoxygenase
Current Drug Targets Diagnosis and Prognostic Evaluation for Xerostomia Using Dynamic MR Sialography
Current Medical Imaging Macrolide Therapy Targets a Specific Phenotype in Respiratory Medicine: From Clinical Experience to Basic Science and Back
Inflammation & Allergy - Drug Targets (Discontinued) Modulatory Effects of Peroxisome Proliferator-Activated Receptor-γ on CXCR3 Chemokines
Recent Patents on Inflammation & Allergy Drug Discovery Drug Delivery to the Inner Ear: Strategies and Their Therapeutic Implications for Sensorineural Hearing Loss
Current Drug Delivery Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects
Current Pharmaceutical Design Editorial (Thematic Issue: Novel Therapeutic Strategies for Cardiovascular Disease Treatment: From Molecular Level to Nanotechnology)
Current Pharmaceutical Design